Formulation, optimization and characterization of Betaxolol hydrochloride proniosomes using 3-2 factorial design

V. Viswanath, P. Tulasi
{"title":"Formulation, optimization and characterization of Betaxolol hydrochloride proniosomes using 3-2 factorial design","authors":"V. Viswanath, P. Tulasi","doi":"10.33974/ijrpst.v1i3.161","DOIUrl":null,"url":null,"abstract":"The revolution in nanotechnology has lead to the development of various dosage forms such as vesicular drug delivery and in particular liposomes, niosomes, proniosomes, aquasomes, bilosomes etc. The disad-vantages exhibited by the liposomes, niosomes can be overcome through introduction of proniosomes which are compact liquid crystalline structures and convert to niosomes upon hydration. The investigation is focused on development and optimization of Betaxolol proniosomes using three square factorial design technique with the aid of design expert 11.0 ® trial version. The optimization technique prefers choles-terol and span 60 as independent variables and drug content, vesicular size, and entrapment efficacy as dependent variables. The design generated total 13 formulations among which F10 exhibited 98.1% drug content and 97.3% of entrapment efficacy. In view of other parameters, F10 exhibits 6.5 pH, 3.8 ve-sicular size and follows diffusion mechanism with anomalous drug transport. Hence, the obtained results specify that F10 is optimized and can be opted for commercialization.","PeriodicalId":14281,"journal":{"name":"International Journal of Research in Pharmaceutical Sciences and Technology","volume":"9 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-02-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Research in Pharmaceutical Sciences and Technology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33974/ijrpst.v1i3.161","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

The revolution in nanotechnology has lead to the development of various dosage forms such as vesicular drug delivery and in particular liposomes, niosomes, proniosomes, aquasomes, bilosomes etc. The disad-vantages exhibited by the liposomes, niosomes can be overcome through introduction of proniosomes which are compact liquid crystalline structures and convert to niosomes upon hydration. The investigation is focused on development and optimization of Betaxolol proniosomes using three square factorial design technique with the aid of design expert 11.0 ® trial version. The optimization technique prefers choles-terol and span 60 as independent variables and drug content, vesicular size, and entrapment efficacy as dependent variables. The design generated total 13 formulations among which F10 exhibited 98.1% drug content and 97.3% of entrapment efficacy. In view of other parameters, F10 exhibits 6.5 pH, 3.8 ve-sicular size and follows diffusion mechanism with anomalous drug transport. Hence, the obtained results specify that F10 is optimized and can be opted for commercialization.
盐酸倍他洛尔原质体的制备、优化及3-2因子设计
纳米技术的革命导致了各种剂型的发展,如囊泡给药,特别是脂质体、乳质体、原质体、水质体、胆质体等。脂质体所表现出的缺点可以通过引入原质体来克服,原质体是致密的液晶结构,并在水合作用后转化为乳质体。本研究采用三方因子设计技术,借助design expert 11.0®试用版,对倍他洛尔原体进行开发与优化。以胆固醇和span 60为自变量,以药物含量、囊泡大小和包封效果为因变量进行优化。设计共生成13个配方,其中F10的药含量为98.1%,包封效率为97.3%。考虑到其他参数,F10的pH值为6.5,粒径为3.8,具有异常药物转运的扩散机制。因此,所获得的结果表明F10是优化的,可以选择商业化。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信